Suppr超能文献

描绘接种 HIV 包膜三聚体亚单位疫苗的非人类灵长类动物中的多克隆抗体反应。

Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines.

机构信息

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Cell Rep. 2020 Mar 17;30(11):3755-3765.e7. doi: 10.1016/j.celrep.2020.02.061.

Abstract

Rational immunogen design aims to focus antibody responses to vulnerable sites on primary antigens. Given the size of these antigens, there is, however, potential for eliciting unwanted, off-target responses. Here, we use our electron microscopy polyclonal epitope mapping approach to describe the antibody specificities elicited by immunization of non-human primates with soluble HIV envelope trimers and subsequent repeated viral challenge. An increased diversity of epitopes recognized and the approach angle by which these antibodies bind constitute a hallmark of the humoral response in most protected animals. We also show that fusion peptide-specific antibodies are likely responsible for some neutralization breadth. Moreover, cryoelectron microscopy (cryo-EM) analysis of a fully protected animal reveals a high degree of clonality within a subset of putatively neutralizing antibodies, enabling a detailed molecular description of the antibody paratope. Our results provide important insights into the immune response against a vaccine candidate that entered into clinical trials in 2019.

摘要

理性免疫原设计旨在将抗体反应集中在主要抗原的脆弱部位。然而,由于这些抗原的体积较大,有可能引发不需要的、针对非目标的反应。在这里,我们使用电子显微镜多克隆表位作图方法来描述用可溶性 HIV 包膜三聚体免疫接种非人类灵长类动物并随后进行反复病毒挑战所引起的抗体特异性。识别的表位多样性增加以及这些抗体结合的角度构成了大多数受保护动物体液免疫反应的标志。我们还表明,融合肽特异性抗体可能负责一些中和广度。此外,对完全受保护动物的冷冻电镜 (cryo-EM) 分析揭示了一组假定具有中和作用的抗体中存在高度的克隆性,从而能够对抗体结合位进行详细的分子描述。我们的研究结果为 2019 年进入临床试验的候选疫苗的免疫反应提供了重要的见解。

相似文献

1
Mapping Polyclonal Antibody Responses in Non-human Primates Vaccinated with HIV Env Trimer Subunit Vaccines.
Cell Rep. 2020 Mar 17;30(11):3755-3765.e7. doi: 10.1016/j.celrep.2020.02.061.
4
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
J Virol. 2015 Oct;89(20):10383-98. doi: 10.1128/JVI.01653-15. Epub 2015 Aug 5.
6
Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes.
J Virol. 2019 Sep 30;93(20). doi: 10.1128/JVI.01188-19. Print 2019 Oct 15.
7
Polyclonal antibody responses to HIV Env immunogens resolved using cryoEM.
Nat Commun. 2021 Aug 10;12(1):4817. doi: 10.1038/s41467-021-25087-4.
10
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers .
J Virol. 2018 Jun 13;92(13). doi: 10.1128/JVI.00381-18. Print 2018 Jul 1.

引用本文的文献

1
Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques.
NPJ Vaccines. 2025 Aug 20;10(1):200. doi: 10.1038/s41541-025-01252-4.
4
Mapping the antibody response to Lassa virus vaccination of non-human primates.
EBioMedicine. 2025 Apr;114:105673. doi: 10.1016/j.ebiom.2025.105673. Epub 2025 Mar 31.
5
Immunofocusing on the conserved fusion peptide of HIV envelope glycoprotein in rhesus macaques.
bioRxiv. 2025 Jun 5:2024.11.27.625755. doi: 10.1101/2024.11.27.625755.
8
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site.
Sci Immunol. 2024 Aug 30;9(98):eadk9550. doi: 10.1126/sciimmunol.adk9550.
9

本文引用的文献

1
HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite.
Sci Adv. 2020 Jun 5;6(23):eaba0512. doi: 10.1126/sciadv.aba0512. eCollection 2020 Jun.
2
Conformational Plasticity in the HIV-1 Fusion Peptide Facilitates Recognition by Broadly Neutralizing Antibodies.
Cell Host Microbe. 2019 Jun 12;25(6):873-883.e5. doi: 10.1016/j.chom.2019.04.011.
3
Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance.
Cell. 2019 May 16;177(5):1153-1171.e28. doi: 10.1016/j.cell.2019.04.012. Epub 2019 May 9.
4
Vaccine-Induced Protection from Homologous Tier 2 SHIV Challenge in Nonhuman Primates Depends on Serum-Neutralizing Antibody Titers.
Immunity. 2019 Jan 15;50(1):241-252.e6. doi: 10.1016/j.immuni.2018.11.011. Epub 2018 Dec 11.
6
A Neutralizing Antibody Recognizing Primarily N-Linked Glycan Targets the Silent Face of the HIV Envelope.
Immunity. 2018 Mar 20;48(3):500-513.e6. doi: 10.1016/j.immuni.2018.02.013. Epub 2018 Mar 13.
7
Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques.
PLoS Pathog. 2018 Feb 23;14(2):e1006913. doi: 10.1371/journal.ppat.1006913. eCollection 2018 Feb.
8
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.
AIDS Res Ther. 2017 Sep 12;14(1):50. doi: 10.1186/s12981-017-0178-3.
10
Progress in HIV vaccine development.
Hum Vaccin Immunother. 2017 May 4;13(5):1018-1030. doi: 10.1080/21645515.2016.1276138. Epub 2017 Mar 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验